National Institutes of Health (NIH) Investor
.jpeg)
Phase II SBIR Grant
Technology:
Cell_Therapies
Headquarters:
United States
Funding Status:
Private
Number Of Exits:
3
Investors Number:
24
Register and Claim Ownership